{
    "nctId": "NCT01215123",
    "briefTitle": "An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Breast Cancer",
    "officialTitle": "Avastin in First Line Metastatic or Recurrent Breast Cancer. Retrospective Phase IV Study",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 28,
    "primaryOutcomeMeasure": "Time to Disease Progression (TDP)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients with metastatic breast cancer in first line treatment who have completed treatment with Avastin\n\nExclusion Criteria:\n\n* Patients not willing or unable to signed written consent form",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}